Alto Neuroscience vs Caris Life Sciences
Alto Neuroscience vs Caris Life Sciences, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alto Neuroscience is on 43/100 and Caris Life Sciences on 59/100.
Where each one leads
Alto Neuroscience
Leads on none of the measures we hold for both companies.
Caris Life Sciences
- our overall score: 59/100 against 43/100
- domain rating: 63/100 against 44/100
- headcount: 1,659 against 86
- funding raised: $700M against $370M
- LinkedIn following: 77,698 against 24,482
At a glance
| Measure | Alto Neuroscience | Caris Life Sciences |
|---|---|---|
| What it is | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2019 | 2008 |
| Headquarters | Los Altos, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alto Neuroscience | Caris Life Sciences |
|---|---|---|
| Employees | 86 | 1,659 |
| Total funding | $370M | $700M |
| Latest round | Registered Direct Offering | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | 24,482 | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alto Neuroscience | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 59/100 |
| Traction | 59/100 | 60/100 |
| Community | 13/100 | Not published |
| Search visibility | 35/100 | 22/100 |
| Quality | 45/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alto Neuroscience | Caris Life Sciences |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Tag Manager |
Alto Neuroscience vs Caris Life Sciences: common questions
Which is better, Alto Neuroscience or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Alto Neuroscience and Caris Life Sciences compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 43/100), domain rating (63/100 against 44/100), headcount (1,659 against 86), funding raised ($700M against $370M), LinkedIn following (77,698 against 24,482).
Read the full Alto Neuroscience review and pricing or the Caris Life Sciences review and pricing. You can also browse other Alto Neuroscience alternatives we track.